EverSource Wealth Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.4K | Sell |
211
-50
| -19% | -$8.63K | ﹤0.01% | 1829 |
|
|
2025
Q1 | $40.7K | Buy |
261
+49
| +23% | +$7.64K | ﹤0.01% | 1332 |
|
|
2024
Q4 | $29.2K | Sell |
212
-3
| -1% | -$413 | ﹤0.01% | 1438 |
|
|
2024
Q3 | $32.1K | Buy |
215
+1
| +0.5% | +$149 | ﹤0.01% | 1259 |
|
|
2024
Q2 | $28.6K | Buy |
214
+39
| +22% | +$5.21K | ﹤0.01% | 1343 |
|
|
2024
Q1 | $24.2K | Sell |
175
-158
| -47% | -$21.9K | ﹤0.01% | 1272 |
|
|
2023
Q4 | $41.9K | Buy |
333
+91
| +38% | +$11.5K | ﹤0.01% | 966 |
|
|
2023
Q3 | $22.7K | Buy |
242
+152
| +169% | +$14.2K | ﹤0.01% | 1081 |
|
|
2023
Q2 | $8.03K | Buy |
90
+30
| +50% | +$2.68K | ﹤0.01% | 1545 |
|
|
2023
Q1 | $6.43K | Buy |
60
+25
| +71% | +$2.68K | ﹤0.01% | 1552 |
|
|
2022
Q4 | $4.28K | Hold |
35
| – | – | ﹤0.01% | 1667 |
|
|
2022
Q3 | $4K | Buy |
+35
| New | +$4K | ﹤0.01% | 1412 |
|
|
2022
Q1 | – | Sell |
-10
| Closed | -$1K | – | 1703 |
|
|
2021
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1677 |
|